Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10 USD | +0.81% | -11.43% | -11.90% |
05-09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
05-09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.90% | 196M | |
+5.66% | 111B | |
+11.23% | 105B | |
-12.15% | 22.34B | |
-3.67% | 21.93B | |
-6.17% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- Baird Initiates INmune Bio at Outperform With $16 Price Target